Uncategorized

Black fungus: 1,06,300 vials of Amphotericin-B allocated to states, UTs

Union minister for chemicals and fertilisers DV Sadananda Gowda on Monday said that 1,06,300 vials of black fungus drugs Amphotericin B have been allocated to states, UTs and to the central institutions.
“Ensuring significant availability of Liposomal #Amphotericin B, additional 1,06,300 vials of the drug have been allocated across all the states/UTs and central institutions today,” Sadananda Gowda said in a tweet.

The minister said that a total of 53,000 vials of Conventional Amphotericin B have also been allocated to all the states, UTs and
central institutions today.
“A total of 53,000 vials of Conventional #Amphotericin B have also been allocated to all the states/UTs & central institutions today. The allocation of #ConventionalAmphotericin B is being made to ensure its smooth supply and timely treatment of patients,” he said in another tweet.

He further said that additional 9,400 vials of Liposomal Amphotericin B and 4,680 vials of Conventional Amphotericin B have been allocated to Karnataka today.
“Additional 9,400 vials of Liposomal Amphotericin B have been allocated to Karnataka today. So far, total 49,870 vials of the drug have been made to the state. Besides this, 4,680 vials of Conventional Amphotericin B have also been allocated to Karnataka today,” he added.
On May 27, the Central government gave a licence to five companies to ramp up the production of Liposomal Amphotericin B injections, which is used to treat black fungus or mucormycosis.

 

The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies